Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study
- Resource Type
- Article
- Source
- In
American Journal of Transplantation December 2015 15(12):3166-3173 - Subject
- Language
- ISSN
- 1600-6135